You have 9 free searches left this month | for more free features.

recurrent childhood brain stem glioma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United

Completed
  • Neurofibromatosis Type 1
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Los Angeles, California
  • +11 more
Apr 22, 2022

Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma Trial in United States (palbociclib

Terminated
  • Childhood Choroid Plexus Tumor
  • +18 more
  • palbociclib isethionate
  • +2 more
  • Los Angeles, California
  • +10 more
Feb 10, 2021

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • SC-CAR4BRAIN
  • Seattle, Washington
    Seattle Children's Hospital
Mar 3, 2023

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

Not yet recruiting
  • Recurrent Glioblastoma, IDH-Wildtype
  • +2 more
  • Biospecimen Collection
  • +2 more
  • (no location specified)
May 13, 2023

Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection)

Recruiting
  • Glioblastoma
  • Glioma, Malignant
  • Biological sample collection
  • Rome, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Mar 6, 2023

Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +5 more
  • Re-irradiation
  • (no location specified)
Oct 16, 2023

Recurrent Medulloblastoma, Recurrent Brain Tumor, Childhood, Malignant Glioma Trial in Durham (PEP-CMV)

Recruiting
  • Recurrent Medulloblastoma
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jan 8, 2022

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn
  • Recurrent Anaplastic Astrocytoma
  • +7 more
  • Neural Stem Cells-expressing CRAd-S-pk7
  • Resection
  • (no location specified)
Nov 22, 2022

High Grade Glioma Trial in Phoenix (BDTX-1535)

Not yet recruiting
  • High Grade Glioma
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Oct 2, 2023

Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,

Recruiting
  • Brain Metastases
  • +3 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Bevacizumab Injection
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

Completed
  • Glioma
  • +7 more
  • Neural stem cells loaded with an oncolytic adenovirus
  • Duarte, California
  • +1 more
Dec 28, 2022

Primary Brain Tumor, Brain Tumor, Recurrent Trial in Durham (Fluoxetine, Temozolomide)

Not yet recruiting
  • Primary Brain Tumor
  • Brain Tumor, Recurrent
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University
Dec 20, 2022

Healthy Volunteers, Recurrent Glioma, Brain Metastases From Extra-cranial Solid Tumors Trial ([F-18]MeFAMP PET)

Not yet recruiting
  • Healthy Volunteers
  • +2 more
  • [F-18]MeFAMP PET
  • (no location specified)
Jan 4, 2023

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Malignant Glioma, Brain Tumor, Recurrent Trial in Durham (D2C7-IT)

    Active, not recruiting
    • Malignant Glioma
    • Brain Tumor, Recurrent
    • Durham, North Carolina
      Preston Robert Tisch Brain Tumor Center at Duke
    Jul 12, 2022

    CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

    Recruiting
    • Central Nervous System Tumor
    • +10 more
    • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
    • Seattle, Washington
      Seattle Children's Hospital
    Dec 14, 2022

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

      Recruiting
      • Anaplastic Ependymoma
      • +14 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 17, 2022

      High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)

      Not yet recruiting
      • High Grade Glioma
      • +3 more
      • Phoenix, Arizona
        St. Joseph's Hospital and Medical Center
      Mar 6, 2023

      Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

      Recruiting
      • Refractory Cancer
      • +14 more
      • Atlanta, Georgia
      • +1 more
      Oct 23, 2023

      Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)

      Terminated
      • Brain and Central Nervous System Tumors
      • Chicago, Illinois
        Rush Cancer Institute at Rush University Medical Center
      Jan 5, 2023

      Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

      Recruiting
      • Recurrent High-grade Glioma
      • +3 more
      • 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
      • +2 more
      • Incheon, Korea, Republic of
        Gachon University Gil Medical Center
      Feb 19, 2023

      Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

      Active, not recruiting
      • Recurrent Anaplastic Astrocytoma
      • +6 more
      • Carboxylesterase-expressing Allogeneic Neural Stem Cells
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Jun 7, 2022